Literature DB >> 10964672

Differential expression of LR11 during proliferation and differentiation of cultured neuroblastoma cells.

S Hirayama1, H Bujo, H Yamazaki, T Kanaki, K Takahashi, J Kobayashi, W J Schneider, Y Saito.   

Abstract

An involvement of the low density lipoprotein receptor (LDLR) gene family in both intracellular signal pathways for neural organization and metabolic pathways for lipoprotein homeostasis is now well established. The discovery of LR11, a mosaic LDLR family member offers the opportunity to gain new insights into receptor multifunctionality. Here, we studied the proliferation-dependent expression of LR11 mRNA and protein using two cultured cell lines, IMR32 neuroblastoma and PC12 pheochromocytoma. Within 24 h, the LR11 protein rose 1.9-fold in proliferating IMR32 cells, and increased further to 5.3-fold at 72 h. This conformed with a transcript level increase of 4.7-fold at 72 h in the proliferating cells. On the other hand, under differentiation conditions, a 2.9-fold increase was observed within 24 h, but at 72 h thereafter the protein levels decreased to 60% of control. The transcript also increased to 1. 8-fold within 24 h, and then decreased to 1.1-fold at 72 h. In order to assess the transcriptional activities of the LR11 gene, we identified the 5'-flanking region of the murine LR11 gene. Transfection of IMR32 and PC12 cells with plasmids containing the whole or deleted fragments of 5'-flanking region showed that element(s) responsible for the above described different transcriptional activities are located in the upstream sequence between -861 and -396. Thus, the transcription of LR11 in these two cell systems is regulated differently during proliferation and differentiation, suggesting that the multifunctionality of LR11, as well as other LDLR family members, for rapid cell growth in malignant cells and neural outgrowth in cultured neurons, respectively. The possible involvement of LR11 in cellular proliferation and differentiation sheds new light on its functions in neurons, malignant, and vascular cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964672     DOI: 10.1006/bbrc.2000.3312

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease.

Authors:  Sara E Dodson; Marla Gearing; Carol F Lippa; Thomas J Montine; Allan I Levey; James J Lah
Journal:  J Neuropathol Exp Neurol       Date:  2006-09       Impact factor: 3.685

2.  The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments.

Authors:  Katrin Offe; Sara E Dodson; James T Shoemaker; Jason J Fritz; Marla Gearing; Allan I Levey; James J Lah
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

3.  An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor.

Authors:  Jenny Blechingberg; Annemarie Svane Aavild Poulsen; Mads Kjølby; Giulia Monti; Mariet Allen; Anne Kathrine Ivarsen; Sarah J Lincoln; Gangadaar Thotakura; Christian B Vægter; Nilüfer Ertekin-Taner; Anders Nykjær; Olav M Andersen
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

4.  Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.

Authors:  Sara E Dodson; Olav M Andersen; Vinit Karmali; Jason J Fritz; Dongmei Cheng; Junmin Peng; Allan I Levey; Thomas E Willnow; James J Lah
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

Review 5.  Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease.

Authors:  Olav M Andersen; Ina-Maria Rudolph; Thomas E Willnow
Journal:  Acta Neuropathol       Date:  2016-09-16       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.